Invesco Nasdaq Biotechnology ETF Rating → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free IBBQ Stock Alerts $21.78 -0.15 (-0.68%) (As of 05/8/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy2.57Holdings in IBBQ have an aggregate rating of Moderate Buy based on 624 analyst ratings issued in the past year covering 50 companies (81.2% of the portfolio).IBBQ Aggregate Price Target$26.2320.45% UpsideHigh Prediction$34.40Average Prediction$26.23Low Prediction$19.01Holdings in IBBQ have an aggregate price target of $26.23 and a range of $19.01 to $34.40 covering 50 companies (81.2% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBBQ Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.99%AMGNAmgen$307.31+2.3%5 of 5 stars2.52$305.05 -0.7%21Earnings ReportAnalyst Revision8.17%REGNRegeneron Pharmaceuticals$955.76-1.5%4 of 5 stars2.70$981.71 2.7%207.86%VRTXVertex Pharmaceuticals$418.82+2.1%4 of 5 stars2.48$432.18 3.2%25Earnings ReportAnalyst Forecast7.47%GILDGilead Sciences$64.92-0.8%5 of 5 stars2.39$83.69 28.9%184.90%MRNAModerna$121.89+0.7%4 of 5 stars2.25$126.89 4.1%16Earnings ReportAnalyst ForecastAnalyst Revision4.63%AZNAstraZeneca$76.97+0.9%2 of 5 stars2.57$81.00 5.2%73.38%BIIBBiogen$219.72+0.4%5 of 5 stars2.65$290.92 32.4%26Positive News2.00%ALNYAlnylam Pharmaceuticals$152.29-1.3%5 of 5 stars2.59$216.19 42.0%17Earnings ReportAnalyst Forecast1.98%ILMNIllumina$110.62-2.0%5 of 5 stars2.30$164.65 48.8%20Earnings ReportAnalyst ForecastAnalyst Revision1.63%BMRNBioMarin Pharmaceutical$81.83-0.9%5 of 5 stars2.63$107.50 31.4%19Insider Selling1.48%NBIXNeurocrine Biosciences$139.02-2.9%5 of 5 stars2.74$147.88 6.4%23Analyst Revision1.47%VTRSViatris$11.81+0.8%0 of 5 stars1.33$11.00 -6.9%3News Coverage1.42%SNYSanofi$50.10+1.1%3 of 5 stars2.40$55.00 9.8%51.34%RPRXRoyalty Pharma$27.99-1.0%5 of 5 stars3.00$46.75 67.0%41.33%SRPTSarepta Therapeutics$132.58-2.5%4 of 5 stars2.79$160.60 21.1%14Insider SellingAnalyst Revision1.29%UTHRUnited Therapeutics$261.09-1.9%5 of 5 stars2.90$308.78 18.3%10Earnings ReportInsider Selling1.29%MEDPMedpace$387.61-3.6%5 of 5 stars2.80$443.00 14.3%51.28%ARGXargenx$386.08-3.2%3 of 5 stars2.71$528.16 36.8%21News Coverage1.28%INCYIncyte$53.51-1.6%5 of 5 stars2.47$74.93 40.0%17Gap Down0.98%ROIVRoivant Sciences$11.21-1.5%4 of 5 stars2.90$16.90 50.8%10Positive News0.95%BNTXBioNTech$90.13-0.8%3 of 5 stars2.27$118.82 31.8%11Analyst ForecastOptions Volume0.81%ASNDAscendis Pharma A/S$133.93-1.5%1 of 5 stars2.88$173.88 29.8%80.76%PCVXVaxcyte$66.79-1.1%1 of 5 stars3.00$78.50 17.5%4Upcoming Earnings0.72%JAZZJazz Pharmaceuticals$110.70-0.5%5 of 5 stars2.85$192.75 74.1%13Insider Selling0.72%ITCIIntra-Cellular Therapies$67.00-5.9%5 of 5 stars2.90$90.17 34.6%10Earnings ReportAnalyst ForecastNews Coverage0.71%BGNEBeiGene$164.44+2.4%3 of 5 stars2.80$250.13 52.1%10Gap Up0.70%EXELExelixis$21.59-2.5%5 of 5 stars2.63$26.33 22.0%16Analyst Revision0.70%CYTKCytokinetics$65.270.0%4 of 5 stars2.87$79.33 21.5%15Analyst ForecastInsider SellingNews Coverage0.68%RVMDRevolution Medicines$38.31-1.5%3 of 5 stars3.10$41.20 7.5%10Gap Down0.68%BPMCBlueprint Medicines$108.78+0.2%1 of 5 stars2.50$100.31 -7.8%16Analyst ForecastInsider SellingAnalyst RevisionNews Coverage0.65%IONSIonis Pharmaceuticals$40.16-1.9%4 of 5 stars2.71$59.54 48.3%14Earnings ReportAnalyst ForecastInsider SellingNews Coverage0.62%APLSApellis Pharmaceuticals$42.30-3.6%5 of 5 stars2.87$76.67 81.2%15Earnings ReportAnalyst Forecast0.55%IBRXImmunityBio$7.92-4.1%0 of 5 stars2.00$6.00 -24.2%1Gap Down0.54%HALOHalozyme Therapeutics$42.01+1.9%5 of 5 stars2.86$53.29 26.8%7Analyst ForecastNews Coverage0.52%BBIOBridgeBio Pharma$27.70-0.3%5 of 5 stars2.80$47.82 72.6%100.50%MDGLMadrigal Pharmaceuticals$208.04-4.6%5 of 5 stars2.73$351.45 68.9%11Earnings ReportAnalyst ForecastNews CoverageGap Down0.48%CRSPCRISPR Therapeutics$53.29-4.0%3 of 5 stars2.38$76.29 43.2%16Upcoming EarningsGap Down0.46%KRYSKrystal Biotech$157.68-2.5%4 of 5 stars3.00$171.00 8.4%9Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.45%IMVTImmunovant$29.76+0.6%3 of 5 stars3.00$48.00 61.3%17Positive News0.44%ALPNAlpine Immune Sciences$64.70+0.1%2 of 5 stars2.27$50.33 -22.2%110.42%NUVLNuvalent$67.54-1.6%3 of 5 stars2.90$90.78 34.4%10Upcoming EarningsInsider Selling0.42%ALKSAlkermes$24.10-2.0%5 of 5 stars2.50$35.38 46.8%10Analyst Revision0.41%IOVAIovance Biotherapeutics$13.39-4.2%5 of 5 stars3.00$24.64 84.0%10Upcoming EarningsOptions Volume0.40%INSMInsmed$26.00-0.3%4 of 5 stars3.00$44.92 72.8%12Upcoming EarningsAnalyst DowngradeNews Coverage0.38%LEGNLegend Biotech$45.72-0.6%2 of 5 stars2.92$82.64 80.8%12Upcoming Earnings0.38%AXSMAxsome Therapeutics$75.68-1.6%4 of 5 stars2.92$122.17 61.4%13Analyst ForecastAnalyst RevisionNews Coverage0.37%RAREUltragenyx Pharmaceutical$41.56-1.0%4 of 5 stars2.92$87.85 111.4%12Earnings ReportAnalyst Forecast0.36%SWTXSpringWorks Therapeutics$42.26-7.6%1 of 5 stars3.00$68.83 62.9%6Earnings ReportAnalyst Forecast0.34%XENEXenon Pharmaceuticals$42.93-1.2%3 of 5 stars3.00$59.44 38.5%9News Coverage0.34%CRNXCrinetics Pharmaceuticals$50.89+6.8%4 of 5 stars2.92$57.58 13.2%12Analyst ForecastNews CoverageGap UpHigh Trading Volume This page (NASDAQ:IBBQ) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
